Trending Now
Kadmon Holdings Inc. (NASDAQ:KDMN) Announces Acceptance Of Belumosudil NDA In Treatment...
Kadmon Holdings Inc. (NASDAQ:KDMN) has announced that the US FDA has accepted its New Drug Application for its Rho-associated coiled-coil kinase-2 inhibitor,...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Progenity Inc. (NASDAQ: PROG) Receives Single-Molecule Detection Platform Patent From USPTO
Progenity Inc. (NASDAQ: PROG) has announced a new patent associated with a single-molecule detection platform currently under development.
The patent covers single target nucleic acid...
MAKE IT MODERN
LATEST REVIEWS
The Virus Testing Boom is Upon Us (CODX, DGX, RXMD, LH)
Trump even said it himself on Tuesday: “It’s going to get worse before it gets better.”
We keep hitting new highs among coronavirus infections, hospitalization,...
MAKE IT MODERN
PERFORMANCE TRAINING
Market’s could rally into Thank Giving Friday (QQQ)
In a light volume Thanksgiving week where not much news in the Macro environment is coming out in the U.S to change...
Blink Charging Co. (Nasdaq:BLNK) Builds Momentum as Shares Tumble
Blink Charging Co. (Nasdaq:BLNK) is an interesting stock to watch as a weathervane for the EV space and for small-cap growth stocks...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Announce That The RELIEF TNX-102 SL Study In Fibromyalgia...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced that its Phase 3 RELIEF study of TNX-102 SL met its primary endpoint. TNX-102 SL...
Geneos Therapeutics Reports Positive Preliminary Results Of GNOS-PV02, A Personalized Vaccine, In A Phase...
Geneos Therapeutics is pleased to report positive preliminary results of GT-30 of GNOS-PV02, a personalized vaccine, combined with pembrolizumab and plasmid pIL-12 in patients...
Curaleaf Holdings Inc (OTCMKTS:CURLF) Searches for Rock Bottom with Latest Expansion
Curaleaf Holdings Inc (OTCMKTS:CURLF), one of the leaders in the North American MSO cannabis space, just announced plans to open two new...
MAKE IT MODERN
